|
| 1 |
Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
Masaya Uno, Rie Matsuo, Naoki Maezawa, Tomoyasu Kato
Obstet Gynecol Sci.2023;66(4):290-299. Published online 2023 July 15
DOI: http://dx.doi.org/10.5468/ogs.23024
|
|
| 2 |
GBA inhibition suppresses ovarian cancer growth, survival and receptor tyrosine kinase AXL-mediated signaling pathways
Gang Wang, Baisha Ouyang, Fang Jing, Xiaoyan Dai
|
|
| 3 |
Characterization of a conjugated polysuccinimide-carboplatin compound
Sun Young Lee, Chang Hoon Chae, Miklós Zrínyi, Xiangguo Che, Je Yong Choi, Dong-Hyu Cho
|
|
| 4 |
Comprehensive clinical characterization of patients with BRCA1: c.5017_5019del germline variant
Yoon Ju Bang, Won Kyung Kwon, Jong-Won Kim, Jeong Eon Lee, Boo Yeon Jung, Mina Kim, Jisun Kim, Jeongshin An, Seung Pil Jung, Hong-Kyu Kim, Zisun Kim, Hyun Jo Youn, Jai Min Ryu, Sung-Won Kim,
|
|
| 5 |
Cost-effective BRCA Testing in Advanced Ovarian Cancer
Myungshin Kim
Ann Lab Med.2023;43(1):3-4. Published online 2022 September 1
DOI: http://dx.doi.org/10.3343/alm.2023.43.1.3
|
|
| 6 |
Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer
Jaehyeok Jang, Yoonjung Kim, Jae-Hoon Kim, Sun-Mi Cho, Kyung-A Lee
Ann Lab Med.2023;43(1):73-81. Published online 2022 September 1
DOI: http://dx.doi.org/10.3343/alm.2023.43.1.73
|
|
| 7 |
Clinical outcomes of immunohistochemistry of the p53 Staining pattern in high-grade serous ovarian carcinoma
Panarat Orachum, Amornrat Temtanakitpaisan, Pilaiwan Kleebkaow, Bandit Chumworathayi, Sanguanchoke Luanratanakorn, Apiwat Aue-angkul, Yuwadee Itarat
Obstet Gynecol Sci.2022;65(5):459-467. Published online 2022 July 29
DOI: http://dx.doi.org/10.5468/ogs.22102
|
|
| 8 |
Multiple biomarkers are more accurate than a combination of carbohydrate antigen 125 and human epididymis protein 4 for ovarian cancer screening
Kyung Nam Kang, Eun Young Koh, Ji Young Jang, Chul Woo Kim
Obstet Gynecol Sci.2022;65(4):346-354. Published online 2022 April 21
DOI: http://dx.doi.org/10.5468/ogs.22017
|
|
| 9 |
Incidence and predictive factors for recurrent clear cell ovarian carcinoma: results from a single center in Thailand
Wikanda Hemman, Athithan Rattanaburi
Obstet Gynecol Sci.2022;65(2):188-196. Published online 2022 February 23
DOI: http://dx.doi.org/10.5468/ogs.21313
|
|
| 10 |
Ultrasonographic ovarian mass scoring system for predicting malignancy in pregnant women with ovarian mass
Se Jin Lee, Hye Rim Oh, Sunghun Na, Han Sung Hwang, Seung Mi Lee
Obstet Gynecol Sci.2022;65(1):1-13. Published online 2022 January 15
DOI: http://dx.doi.org/10.5468/ogs.21212
|
|
| 11 |
임상검체에서 BRCA 돌연변이를 검출하는 차세대염기서열분석법의 임상적 효용성 평가
Man Jin Kim, Byeong Ju Song, Si Eun Kim, Chang Seon Lee, Ji-Eun Im, Ensel Oh, Keunsook Lee, Sung Im Cho, Kwang Joong Kim, Sung Sup Park, Moon-Woo Seong
|
|
| 12 |
Prognostic significance of tumor laterality in advanced ovarian cancer
Yuki Yamada, Seiji Mabuchi, Naoki Kawahara, Ryuji Kawaguchi
Obstet Gynecol Sci.2021;64(6):524-531. Published online 2021 September 14
DOI: http://dx.doi.org/10.5468/ogs.21176
|
|
| 13 |
Disparities between Uptake of Germline BRCA1/2 Gene Tests and Implementation of Post-test Management Strategies in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Young Min Hur, Jaehee Mun, Mi-Kyung Kim, Maria Lee, Yun Hwan Kim, Seung-Cheol Kim
|
|
| 14 |
Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review
Sun-young Park, Youlim Kim, Sue Kim
|
|
| 15 |
Sarcopenia as a Predictor of Prognosis in Early Stage Ovarian Cancer
Su Hyun Chae, Chulmin Lee, Sang-Hee Yoon, Seung-Hyuk Shim, Sun Joo Lee, Soo-Nyung Kim, Sochung Chung, Ji Young Lee
|
|
| 16 |
Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
Hyeong In Ha, Eun-Gyeong Lee, Jiwon Lim, So-Youn Jung, Yoon Jung Chang, Young-Joo Won, Myong Cheol Lim
Cancer Res Treat.2021;53(2):541-548. Published online 2020 November 18
DOI: http://dx.doi.org/10.4143/crt.2020.1001
|
|
| 17 |
Building a Lung and Ovarian Cancer Data Warehouse
Canan Eren Atay, Georgia Garani
|
|
| 18 |
Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer
Asami Ikeda, Ken Yamaguchi, Hajime Yamakage, Kaoru Abiko, Noriko Satoh-Asahara, Kenji Takakura, Ikuo Konishi
Obstet Gynecol Sci.2020;63(6):709-718. Published online 2020 September 17
DOI: http://dx.doi.org/10.5468/ogs.20117
|
|
| 19 |
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy
Obstet Gynecol Sci.2020;63(5):643-654. Published online 2020 September 2
DOI: http://dx.doi.org/10.5468/ogs.20033
|
|
| 20 |
A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer
Junsik Park, Kyung Jin Eoh, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim, Jung-Yun Lee
Yonsei Med J.2020;61(4):284-290. Published online 2020 March 25
DOI: http://dx.doi.org/10.3349/ymj.2020.61.4.284
|
|
